Antibodies targeting this region have been demonstrated to have a significant anti-PrP effect, e.g., mAb 6H4 (raised against amino acids 144–152) which clears PrPSc from prion infected neuroblastoma cells [59]. Here, PRNP is linked to neuroblastoma.